Correlation Between Dongbu Insurance and GeneBioTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dongbu Insurance and GeneBioTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dongbu Insurance and GeneBioTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dongbu Insurance Co and GeneBioTech Co, you can compare the effects of market volatilities on Dongbu Insurance and GeneBioTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dongbu Insurance with a short position of GeneBioTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dongbu Insurance and GeneBioTech.

Diversification Opportunities for Dongbu Insurance and GeneBioTech

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Dongbu and GeneBioTech is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Dongbu Insurance Co and GeneBioTech Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneBioTech and Dongbu Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dongbu Insurance Co are associated (or correlated) with GeneBioTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneBioTech has no effect on the direction of Dongbu Insurance i.e., Dongbu Insurance and GeneBioTech go up and down completely randomly.

Pair Corralation between Dongbu Insurance and GeneBioTech

Assuming the 90 days trading horizon Dongbu Insurance Co is expected to under-perform the GeneBioTech. In addition to that, Dongbu Insurance is 1.17 times more volatile than GeneBioTech Co. It trades about -0.07 of its total potential returns per unit of risk. GeneBioTech Co is currently generating about -0.07 per unit of volatility. If you would invest  334,000  in GeneBioTech Co on September 30, 2024 and sell it today you would lose (14,000) from holding GeneBioTech Co or give up 4.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dongbu Insurance Co  vs.  GeneBioTech Co

 Performance 
       Timeline  
Dongbu Insurance 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dongbu Insurance Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Dongbu Insurance is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
GeneBioTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GeneBioTech Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Dongbu Insurance and GeneBioTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dongbu Insurance and GeneBioTech

The main advantage of trading using opposite Dongbu Insurance and GeneBioTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dongbu Insurance position performs unexpectedly, GeneBioTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneBioTech will offset losses from the drop in GeneBioTech's long position.
The idea behind Dongbu Insurance Co and GeneBioTech Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years